RecruitingNCT05144152

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

A Prospective Study to Assess the Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) in Predicting Colorectal Advanced Adenoma Recurrence


Sponsor

Chinese University of Hong Kong

Enrollment

600 participants

Start Date

Dec 13, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Known colorectal adenomas during index colonoscopy;
  • Available baseline M3 and FIT results before index colonoscopy;
  • Aged ≥18 years old;
  • Written informed consent obtained.

Exclusion Criteria8

  • Refusal or unfit to undergo surveillance colonoscopy;
  • Incomplete colonoscopy, incomplete removal of colorectal adenomas, or inadequate bowel preparation (defined as Boston Bowel Preparation Scale score 0 or 1 in any colonic segment) at index colonoscopy;
  • Previous colonic resection;
  • Personal history of colorectal cancer;
  • Personal history of polyposis syndrome;
  • Personal history of inflammatory bowel disease;
  • Known pregnancy or lactation;
  • Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above);

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTM3

A panel of four bacterial gene markers (Fn, m3, Ch and Bc)

DIAGNOSTIC_TESTFIT

faecal immunochemical test


Locations(1)

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05144152


Related Trials